Pharma Major, Ind-Swift Laboratories Limited has collaborated with The Council of Scientific and Industrial Research (CSIR) - Institute of Microbial Technology (IMTECH), a premier microbial institute under the aegis of the Ministry of Science and Technology, Government of India, for development of Biotransformation Process (Enzymatic Process) for its products.
The agreement between Ind-Swift and CSIR-IMTECH will enable scientists from both the organizations to work closely on development of Biotransformation process (Enzymatic Process) for its products. For this project, scientists at IMTECH will utilize their expertise and scientific know how in microbiology while Ind-Swift team will provide its expertise in process chemistry & pharmaceutical drug development's analytical resources.
The Technical teams of CSIR-IMTECH headed by Dr. Sanjeev Khosla, Director CSIR-IMTECH, Dr. Mani Shankar Bhattacharya, Principal Scientists, CSIR-IMTECH and Ind-Swift Laboratories Limited headed by its Chairman and Managing Director, Sh. N.R. Munjal, CEO Sh. Sunil Deshmukh, Dr Ashok Prasad, Head-R&D met at Chandigarh today and exchanged project agreement.
Speaking on the occasion Sh. N.R. Munjal, Chairman and Managing Director Ind-Swift Laboratories expressed that "The field of biotransformation process (Enzymatic Process) is an alternative to traditional chemical processes. This collaboration presents a unique opportunity to enhance our capabilities, drive innovation, and optimize production processes. This approach aligns with the growing demand for eco-friendly and efficient manufacturing in the pharmaceutical sector."
Sh. Sunil Deshmukh, CEO of Ind-Swift Laboratories Limited emphasized the importance of Public Private Partnership (PPP) collaboration as the need of hour to bring out scientific and technical excellence in pharmaceutical sector of India.
CSIR-IMTECH is a national centre for excellence in microbial sciences and was established in 1984 under the aegis of CSIR. IMTECH's vision and mission are to create a translational ecosystem strengthened by fundamental discoveries and to address unmet and industrial needs with state-of-the art processes and platforms.
Ind-Swift Laboratories Limited Headquartered in Chandigarh, India is a global manufacturer of APIs and its Intermediates.
Shares of Ind-Swift Laboratories Limited was last trading in BSE at Rs. 92.50 as compared to the previous close of Rs. 92.61. The total number of shares traded during the day was 22584 in over 686 trades.
The stock hit an intraday high of Rs. 94.46 and intraday low of 92.21. The net turnover during the day was Rs. 2113389.00.